These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17187504)

  • 21. [Personalized treatment of cancer: utopia or chance?].
    Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value and applications of pharmacogenetics in oncology and hematology].
    Albin N; Massade L; Gouyette A
    Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer endocrinology through own experience: areas for further thought and development. Interview by Natasha Galukande.
    Berstein LM
    Future Oncol; 2013 Jul; 9(7):933-7. PubMed ID: 23837755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
    J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardio-oncology: a tremendous opportunity to improve patient care.
    Lenihan DJ; Westcott G
    Future Oncol; 2015; 11(14):2007-10. PubMed ID: 26198827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What do we mean by targeted therapy?
    Sledge GW
    Clin Breast Cancer; 2001 Oct; 2(3):169. PubMed ID: 11899412
    [No Abstract]   [Full Text] [Related]  

  • 29. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease.
    Hobson K
    US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442
    [No Abstract]   [Full Text] [Related]  

  • 30. [Translational research in clinical oncology: challenges and opportunities].
    Díaz-Rubio García E
    An R Acad Nac Med (Madr); 2008; 125(1):105-20; discussion 121-2. PubMed ID: 18777846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of trends in globalisation of origin of research published in major general medical journals.
    Falagas ME; Alexiou VG
    Int J Clin Pract; 2008 Jan; 62(1):71-5. PubMed ID: 18173813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Back to the Future for Clinical Oncology.
    Chabner BA
    Oncologist; 1996; 1(1 & 2):I. PubMed ID: 10387977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The birth of the subspecialty of medical oncology and examples of its early scientific foundations.
    Band PR
    J Clin Oncol; 2010 Aug; 28(22):3653-8. PubMed ID: 20567013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoimaging devices illuminate tumor margins during surgery.
    Patlak M
    J Natl Cancer Inst; 2011 Feb; 103(3):173-4. PubMed ID: 21242334
    [No Abstract]   [Full Text] [Related]  

  • 36. Systems medicine: a real approach for future personalized oncology?
    Roukos DH
    Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacology and pharmacogenetics of chemotherapeutic agents.
    Dawood S; Leyland-Jones B
    Cancer Invest; 2009 Jun; 27(5):482-8. PubMed ID: 19479485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding POEMs in the medical literature.
    Ebell MH; Barry HC; Slawson DC; Shaughnessy AF
    J Fam Pract; 1999 May; 48(5):350-5. PubMed ID: 10334611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where does hematology end and oncology begin? Questions of professional boundaries and medical authority.
    Krueger G; Canellos G
    J Clin Oncol; 2006 Jun; 24(16):2583-8. PubMed ID: 16735712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.